• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Delcath Systems, Inc. - Common Stock (NQ:DCTH)

    9.290 +0.170 (+1.86%)
    Streaming Delayed Price Updated: 2:22 PM EDT, Mar 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 269,642
    Open 9.160
    Bid (Size) 9.250 (300)
    Ask (Size) 9.330 (500)
    Prev. Close 9.120
    Today's Range 9.155 - 9.500
    52wk Range 8.120 - 18.23
    Shares Outstanding 7,906,728
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath (DCTH) Q4 2025 Earnings Call Transcript ↗
    Delcath (DCTH) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    -6.6%
    -6.6%
    1 Month
    -6.6%
    -6.6%
    3 Month
    -3.6%
    -3.6%
    6 Month
    -19.6%
    -19.6%
    1 Year
    -21.3%
    -21.3%

    More News

    Read More
    Delcath Systems Inc (NASDAQ:DCTH) Posts Q4 Beat, Provides Cautious 2026 Outlook ↗
    Via Chartmill
    News headline image
    Delcath Systems Reports Fourth Quarter and Full Year 2025 Results
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Inc (NASDAQ:DCTH) Reports Q3 2025 Revenue Miss, Meets EPS Estimates ↗
    Via Chartmill
    News headline image
    Delcath Systems Reports Third Quarter 2025 Results and Business Highlights
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems to Host Third Quarter 2025 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    News headline image
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Delcath Systems, Inc. - Common Stock publicly traded?
    Yes, Delcath Systems, Inc. - Common Stock is publicly traded.
    What exchange does Delcath Systems, Inc. - Common Stock trade on?
    Delcath Systems, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Delcath Systems, Inc. - Common Stock?
    The ticker symbol for Delcath Systems, Inc. - Common Stock is DCTH on the Nasdaq Stock Market
    What is the current price of Delcath Systems, Inc. - Common Stock?
    The current price of Delcath Systems, Inc. - Common Stock is 9.290
    When was Delcath Systems, Inc. - Common Stock last traded?
    The last trade of Delcath Systems, Inc. - Common Stock was at 03/10/26 02:22 PM ET
    What is the market capitalization of Delcath Systems, Inc. - Common Stock?
    The market capitalization of Delcath Systems, Inc. - Common Stock is 73.45M
    How many shares of Delcath Systems, Inc. - Common Stock are outstanding?
    Delcath Systems, Inc. - Common Stock has 73M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.